Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M208,347Revenue (TTM) $M50,877Net Margin (%)18.9Altman Z-Score3.6
Enterprise Value $M215,578EPS (TTM) $1.4Operating Margin %27.8Piotroski F-Score9
P/E(ttm)22.3Beneish M-Score-2.8Pre-tax Margin (%)25.7Higher ROA y-yY
Price/Book8.910-y EBITDA Growth Rate %1.1Quick Ratio0.9Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %1.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow21.7y-y EBITDA Growth Rate %7.8ROA % (ttm)12.7Higher Current Ratio y-yY
Dividend Yield %3.3PEG20.3ROE % (ttm)45.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,815ROIC % (ttm)27.1Gross Margin Increase y-yY

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RHHBY is held by these investors:



RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RHHBY:

    News about RHHBY:

    Articles On GuruFocus.com
    A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield Jan 24 2017 
    Blake Insomnia CEO Dreams of Improving Sleep Jan 04 2017 
    Roche's Leukemia Drug Approved for Next Step in Europe Dec 11 2016 
    Leith Wheeler Investment Funds 3rd Quarter Review Nov 01 2016 
    Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee Oct 14 2016 
    Mairs and Power Buys Walt Disney, Exits Baxalta Sep 27 2016 
    Is Bristol-Myers Squibb Presenting an Opportunity? Sep 08 2016 
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 
    Innovative Diagnostic and Therapeutic Products Seen at Roche Aug 22 2016 
    Siegfried Holdings, Held by Tweedy Browne, Way Undervalued Jul 22 2016 

    More From Other Websites
    ROCHE HOLDING LTD /FI Financials Mar 01 2017
    Exelixis 4Q Net 12 Cents a Share Vs Loss Last Year Feb 28 2017
    Exelixis In Cancer Deals With Roche, Bristol Myers Feb 28 2017
    Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team Feb 27 2017
    New frontiers in cancer research and treatment to be explored by global experts at Tucson Symposium Feb 27 2017
    Novartis Lung Cancer Drug Combo Gets CHMP Nod Feb 24 2017
    Novartis Cancer Drug Zykadia Gets Priority Review Feb 24 2017
    Patient Dies In Roche Hemophilia Study Feb 24 2017
    Merck, Roche Gouge Bristol's I-O Share After Lung Cancer Approvals Feb 23 2017
    Roche Lung Cancer Drug Alecensa Gets EU Nod Feb 21 2017
    Roche Sues Amgen Over Avastin Biosimilar Drug Feb 20 2017
    Roche says Phase II trial supports twin treatment for kidney cancer Feb 18 2017
    Phase II Study Supports Potential for Genentech’s Tecentriq® (Atezolizumab) Plus Avastin®... Feb 18 2017
    These Are The First Immune-System Cancer Drugs OK'd By FDA Feb 17 2017
    AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink Feb 17 2017
    Prothena (PRTA) Reports Wider-than-Expected Loss in Q4 Feb 15 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)